Skip to main content

Table 2 Comorbidities at presentation.*

From: Do airway metallic stents for benign lesions confer too costly a benefit?

 

n (patients)

% total patients

Chronic obstructive pulmonary disease

14

40.0

Pneumonia

10

28.6

Lung transplant

4

11.4

Interstitial lung disease

4

11.4

Cerebro-vascular accident

3

8.6

Adult respiratory distress syndrome

2

5.7

Other infection (non-respiratory)

2

5.7

Congestive heart failure

2

5.7

Other malignancy

1

2.9

Collage-Vascular Disease

1

2.9

Immunocompromised

1

2.9

Critical illness neuromyopathy

1

2.9

  1. *Patients may have had more than 1 comorbidity. Comorbidities were observed in 89% (n = 31) of patients.